Nocion

formerly Nocion Therapeutics

Home — Nocion Therapeutics

Watertown, United States · Founded 2019 · $134.0M raised

Employees
1–10
Founded
2019
Business Model
B2B
Total Funding
$134.0M
Last Round
$27.0M Series AJan 2026
Rounds
4

About

Nocion Therapeutics is a clinical-stage biopharmaceutical company developing targeted molecules designed to calm overactive sensory nerves at their source. Its lead program, taplucainium dry powder for inhalation, is a first-in-class therapy in late-stage development for refractory or unexplained chronic cough, addressing an estimated 9 million U.S. patients with few effective options.

Summary

Nocion is a Biotech company based in Watertown, United States, founded in 2019. It has raised $134.0M in total across 4 rounds, most recently a $27.0M Series A round in Jan 2026. Investors include Canaan Partners, F-Prime Capital and Arkin Bio Ventures.

Tech & App Stack

3 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BJan 2026
$23.0M

Sign up to see all 4 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies